CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome

被引：73

作者：

Kulkarni, Smita ^{[1
,2
,3
]}

Lied, Alexandra ^{[2
,3
]}

Kulkarni, Viraj ^{[2
,3
]}

Rucevic, Marijana ^{[2
,3
,4
]}

Martin, Maureen P. ^{[5
]}

Walker-Sperling, Victoria ^{[6
]}

Anderson, Stephen K. ^{[5
]}

Ewy, Rodger ^{[1
]}

Singh, Sukhvinder ^{[1
]}

Nguyen, Hoang ^{[1
]}

McLaren, Paul J. ^{[7
,8
]}

Viard, Mathias ^{[5
]}

Naranbhai, Vivek ^{[2
,3
]}

Zou, Chengcheng ^{[9
]}

Lin, Zhansong ^{[9
]}

Gatanaga, Hiroyuki ^{[9
,10
]}

Oka, Shinichi ^{[9
,10
]}

Takiguchi, Masafumi ^{[9
]}

Thio, Chloe L. ^{[11
]}

Margolick, Joseph ^{[12
]}

Kirk, Gregory D. ^{[13
]}

Goedert, James J. ^{[14
]}

Hoots, W. Keith ^{[15
]}

Deeks, Steven G. ^{[16
]}

Haas, David W. ^{[17
]}

Michael, Nelson ^{[18
]}

Walker, Bruce ^{[2
,3
,19
,20
]}

Le Gall, Sylvie ^{[2
,3
]}

Chowdhury, Fatema Z. ^{[2
,3
]}

Yu, Xu G. ^{[2
,3
]}

Carrington, Mary ^{[2
,3
,5
]}

机构：

[1] Texas Biomed Res Inst, San Antonio, TX 78227 USA

[2] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA

[3] Harvard Univ, Cambridge, MA 02138 USA

[4] Olink Prote, Watertown, MA USA

[5] Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD 21701 USA

[6] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA

[7] Publ Hlth Agcy Canada, JC Wilt Infect Dis Res Ctr, Winnipeg, MB, Canada

[8] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada

[9] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan

[10] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan

[11] Johns Hopkins Univ, Dept Med, Baltimore, MD USA

[12] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA

[13] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA

[14] NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, Rockville, MD USA

[15] NHLBI, Div Blood Dis & Resources, NIH, Bldg 10, Bethesda, MD 20892 USA

[16] San Francisco Gen Hosp, Med Ctr, San Francisco, CA 94110 USA

[17] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA

[18] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA

[19] Howard Hughes Med Inst, Chevy Chase, MD USA

[20] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA

来源：

NATURE IMMUNOLOGY | 2019年 / 20卷 / 07期

关键词：

LONG NONCODING RNAS; HOST GENETIC-VARIATION; MESSENGER-RNA; VIRUS REPLICATION; EXPRESSION; INFECTION; PROGRESSION; CELLS; HEPATITIS; DENSITY;

D O I：

10.1038/s41590-019-0406-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Multiple genome-wide studies have identified associations between outcome of human immunodeficiency virus (HIV) infection and polymorphisms in and around the gene encoding the HIV co-receptor CCR5, but the functional basis for the strongest of these associations, rs1015164A/G, is unknown. We found that rs1015164 marks variation in an activating transcription factor 1 binding site that controls expression of the antisense long noncoding RNA (lncRNA) CCR5AS. Knockdown or enhancement of CCR5AS expression resulted in a corresponding change in CCR5 expression on CD4(+) Tcells. CCR5AS interfered with interactions between the RNA-binding protein Raly and the CCR5 3' untranslated region, protecting CCR5 messenger RNA from Raly-mediated degradation. Reduction in CCR5 expression through inhibition of CCR5AS diminished infection of CD4(+) Tcells with CCR5-tropic HIV in vitro. These data represent a rare determination of the functional importance of a genome-wide disease association where expression of a lncRNA affects HIV infection and disease progression.

引用

页码：824 / +

页数：13

共 50 条

[11] Structural and molecular interactions of CCR5 inhibitors with CCR5
Maeda, K
Das, D
Ogata-Aoki, H
Nakata, H
Miyakawa, T
Tojo, Y
Norman, R
Takaoka, Y
Ding, JP
Arnold, GF
Arnold, E
Mitsuya, H
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (18) : 12688 - 12698
[12] The HIV co-receptor CCR5 regulates osteoclast function
Lee, Ji-Won
Hoshino, Akiyoshi
Inoue, Kazuki
Saitou, Takashi
Uehara, Shunsuke
Kobayashi, Yasuhiro
Ueha, Satoshi
Matsushima, Kouji
Yamaguchi, Akira
Imai, Yuuki
Iimura, Tadahiro
NATURE COMMUNICATIONS, 2017, 8
[13] The HIV co-receptor CCR5 regulates osteoclast function
Ji-Won Lee
Akiyoshi Hoshino
Kazuki Inoue
Takashi Saitou
Shunsuke Uehara
Yasuhiro Kobayashi
Satoshi Ueha
Kouji Matsushima
Akira Yamaguchi
Yuuki Imai
Tadahiro Iimura
Nature Communications, 8
[14] The role of the gene CCR5 polymorphisms CCR5Δ32 e CCR5 59029 in ocular toxoplasmosis.
Faria Junior, G. M.
Ayo, C. M.
Murata, F. H. A.
Frederico, F. B.
Lopes, A. G.
Oliveira, A. P.
de Mattos, L. C.
de Mattos, C. C. B.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 110 - 110
[15] The extent of genetic variation in the CCR5 gene
AnsariLari, MA
Liu, XM
Metzker, ML
Rut, AR
Gibbs, RA
NATURE GENETICS, 1997, 16 (03) : 221 - 222
[16] The extent of genetic variation in the CCR5 gene
M. Ali Ansari-Lari
Xiao-Mei Liu
Michael L. Metzker
Andrew R. Rut
Richard A. Gibbs
Nature Genetics, 1997, 16 : 221 - 222
[17] CRISPR in HIV: dangers of CCR5 deletion
Rusconi, Stefano
Giacomelli, Andrea
FUTURE VIROLOGY, 2020, 15 (04) : 207 - 210
[18] Endocytosis and recycling of the HIV coreceptor CCR5
Signoret, N
Pelchen-Matthews, A
Mack, M
Proudfoot, AEI
Marsh, M
JOURNAL OF CELL BIOLOGY, 2000, 151 (06): : 1281 - 1293
[19] On the dimerization of CCR5
Lemay, J
Marullo, S
Jockers, R
Alizon, M
Brelot, A
NATURE IMMUNOLOGY, 2005, 6 (06) : 535 - 535
[20] On the dimerization of CCR5
Julie Lemay
Stefano Marullo
Ralf Jockers
Marc Alizon
Anne Brelot
Nature Immunology, 2005, 6 : 535 - 535

← 1 2 3 4 5 →